From: Downregulation of EphA5 by promoter methylation in human prostate cancer
 | Prostate cancer (%) | BPH (%) |
---|---|---|
Case, n | 45 | 39 |
Age (mean ± SD, years) | 69.5 ± 10.3 | 63.6 ± 9.1 |
TNM | ||
T1 | 1 (2.2) | Â |
T2 | 12 (26.7) | |
T3 | 14 (31.1) | |
T4 | 18 (40.0) | |
Gleason score | ||
6-7 | 22 (48.9) | Â |
8-10 | 23 (51.1) | |
PSA (ng/ml) | ||
<4.0 | 2 (4.4) | 4 (10.3) |
4.0–10.0 | 7 (15.6) | 21 (53.8) |
>10.0 | 36 (80.0) | 14 (35.9) |
Prostate volume (ml) | ||
<30 | 14 (31.1) | 8 (20.5) |
30–50 | 17 (37.8) | 12 (30.8) |
>50 | 14 (31.1) | 19 (48.7) |